Printer Friendly

Articles from M2 Pharma (July 18, 2017)

1-24 out of 24 article(s)
Title Author Type Words
Abzena signs licence agreement with Telix for its prostate-specific membrane antigen antibodies. 252
Apexigen Doses First Patient in Clinical Trial of APX005M in Combination with Opdivo (nivolumab) in Advanced Solid Tumors. 320
Asterias Biotherapeutics Doses Fifth Patient in SCiStar Study's AIS-A 20 m Cell Cohort. Clinical report 383
Audentes Therapeutics Names Mavilio as VP Scientific Affairs, Europe. 271
AXON Neuroscience completes recruitment round for Alzheimer's phase II clinical trial. 265
Emergent BioSolutions to acquire smallpox vaccine business from Sanofi. 198
Enzymatica hires Claus Egstrand as chief commercial officer. 175
Equicare Health Adds Support for Interoperability with Varian's Aria 15.1. 283
FDA approves Alembic Pharmaceuticals' ANDA for Olmesartan Medoxomil and Amlodipine tablets. 160
Global Organ Transplant Immunosuppressant Market to Grow at a CAGR of 3.8% by 2021, Research and Markets Forecasts. 350
J+D Consulting names new business analyst. 113
Johnson & Johnson declares dividend of USD0.84 per share for Q3 2017. 137
Lannett Names Israel as General Counsel. 147
Los Named Chief Scientific Officer at Phoenix Molecular Designs. 492
Mayo Clinic and nference collaborate to set up Qrativ. 152
New Neurology Program Earns Ionis USD 10m Milestone Payment from Biogen. 130
PeptiDream and Kleo Pharmaceuticals form collaboration agreement. 243
Research finds that UK cancer survival rates lag behind large European countries. 567
Sunovion Pharmaceuticals grants Covis Pharma US market rights to ciclesonide products. 130
Sutro ADC Targets CD74, Eradicates B-Cell Hematologic Malignancy, Prolongs Survival. 341
Takeda enters research collaboration with Prana for treatment of Parkinson's disease gastrointestinal neuropathology. 198
UK's Department of Health to provide more than GBP120m funding to 33 research units and groups. 201
UK-led Alzheimer's disease drug trial needs more participants. 602
US FDA Approves Impax Generic Concerta Extended-Release Tablets. 202

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters